These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. A model of labelled-ligand displacement assays resulting in logit-log relationships. Smith SW J Theor Biol; 1982 Oct; 98(3):475-99. PubMed ID: 7176679 [No Abstract] [Full Text] [Related]
44. Useful clinical assays for vitamin D metabolites. Clemens TL Trends Endocrinol Metab; 1990; 1(3):129-33. PubMed ID: 18411105 [TBL] [Abstract][Full Text] [Related]
45. Measurement of plasma 1,25 dihydroxyvitamin D using a novel immunoextraction technique and immunoassay with iodine labelled vitamin D tracer. Fraser WD; Durham BH; Berry JL; Mawer EB Ann Clin Biochem; 1997 Nov; 34 ( Pt 6)():632-7. PubMed ID: 9367000 [TBL] [Abstract][Full Text] [Related]
46. Sensitive measurement of serum 1α,25-dihydroxyvitamin D by liquid chromatography/tandem mass spectrometry after removing interference with immunoaffinity extraction. Yuan C; Kosewick J; He X; Kozak M; Wang S Rapid Commun Mass Spectrom; 2011 May; 25(9):1241-9. PubMed ID: 21488122 [TBL] [Abstract][Full Text] [Related]
47. Coexisting primary hyperparathyroidism and sarcoidosis cause increased angiotensin-converting enzyme and decreased parathyroid hormone and phosphate levels. Lim V; Clarke BL J Clin Endocrinol Metab; 2013 May; 98(5):1939-45. PubMed ID: 23493435 [TBL] [Abstract][Full Text] [Related]
48. Vitamin D and its metabolites--supply of patients with various endocrine disorders and comparison of analytical methods. Vosatkova M; Hoskovcova P; Bilek R Endocr Regul; 2007 Mar; 41(1):19-28. PubMed ID: 17437341 [TBL] [Abstract][Full Text] [Related]
49. Analogs of 1α,25-Dihydroxyvitamin D₃ in Clinical Use. DeLuca HF; Plum LA Vitam Horm; 2016; 100():151-64. PubMed ID: 26827952 [TBL] [Abstract][Full Text] [Related]
50. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
51. Strategies to minimize bone disease in renal failure. Martin KJ; González EA Am J Kidney Dis; 2001 Dec; 38(6):1430-6. PubMed ID: 11728986 [TBL] [Abstract][Full Text] [Related]
52. Vitamin D analogs as therapeutic agents: a clinical study update. Wu-Wong JR; Tian J; Goltzman D Curr Opin Investig Drugs; 2004 Mar; 5(3):320-6. PubMed ID: 15083599 [TBL] [Abstract][Full Text] [Related]
53. [Measurement of circulating 1,25-dihydroxyvitamin D employing radioimmunoassay]. Yamamoto I; Hamazu H; Kigami Y; Morita R Kaku Igaku; 1997 Apr; 34(4):243-50. PubMed ID: 9183148 [TBL] [Abstract][Full Text] [Related]